https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
05). The proportion of haplotype "HLA-DQB1*0502-DRB1*1501" was significantly greater in the NMOSD patients than the controls, at 8.42% and 1.23%, respectively (p0.001, OR7.39). The gene burden analysis demonstrated that loss-of-function mutations in NOP16 were more common in the NMOSD patients (11.84%) than the controls (5.71%; p0.001, OR2.22). The IgG1-G390R variant was significantly more common in NMOSD, and the rate of the T allele was 0.605 in patients and 0.345 in the controls (p0.01, OR2.92). The enrichmen
Like
Comment
Share
